Glaxosmithkline Share News (GSK)

BROKER RATINGS SUMMARY: Charles Stanley Says Accumulate AstraZeneca

Dividends Calendar - Week Ahead

Dividends Calendar - Week Ahead

Ex-divs to take around 34 points off FTSE 100 on Aug. 13

LONDON, Aug 10 (Reuters) - The following FTSE 100 companies will go ex-dividend on Thursday, after which investors will no longer qualify for the latest dividend payout. According to Reuters calculations at current market prices, the effect of the resulting adjustment to prices by market-mak

Dividends Calendar - Week Ahead

Dividends Calendar - Week Ahead

TOP NEWS SUMMARY: UK Trade Deficit Widens; William Hill Shares Slump

BROKER RATINGS SUMMARY: Panmure Cuts Travis Perkins To Sell From Hold

LONDON BRIEFING: Investors Await US Jobs Data; William Hill Slumps

LONDON MARKET PRE-OPEN: Stocks Pointed Lower; Focus On US Job Data

Glaxo Gets Canadian Approval For Asthma Treatment BREO ELLIPTA

Dividends Calendar - Week Ahead

BUZZ-GSK v Shire: diverging fortunes

** GSK rises 2.7 pct on multiple reports of bid spec, adding to reasons to have the firm as a top pick in pharma after a lacklustre YTD ** Talk doing the rounds that Pfizer a possible bidder at £19/shr ** Valuation compelling, most notably as a pair trade against UK-listed peer Shire

Dividends Calendar - Week Ahead

BUZZ-UK high-dividend stocks: rally as UK rate-hike fears recede

** Shares in big UK dividend yielders underpinned as 'Super Thursday' dispels rate-hike worries ** GlaxoSmithKline up 2.7%. One trader attributes strength to divi attractions, stock spiked after BoE announcement at 1100 GMT (divi yield 5.6%); resurfaced Pfizer bid talk also a factor